+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Contract Research and Manufacturing Service (CRAMS) Market in India 2025-2029

  • PDF Icon

    Report

  • 197 Pages
  • February 2025
  • Region: India
  • TechNavio
  • ID: 5976391
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The contract research and manufacturing service (CRAMS) market in India is forecasted to grow by USD 17.11 billion during 2024-2029, accelerating at a CAGR of 11.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by diverse range of service offerings by CRAMS providers, availability of cost-effective solutions for research, development, and manufacturing services, and presence of highly skilled workforce in pharmaceutical sciences and biotechnology.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The contract research and manufacturing service (CRAMS) market in India is segmented as below:

By Service

  • Manufacturing
  • Research

By Therapeutic Area

  • Cardiovascular
  • Infectious disease
  • Endocrine disease
  • Oncology
  • Others

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic and research institutes

By Technology

  • Bioinformatics
  • Combinatorial chemistry
  • High-throughput screening
  • Spectroscopy
  • Others

By Geographical Landscape

  • APAC
This study identifies the technological advancements in CRAMS as one of the prime reasons driving the contract research and manufacturing service (CRAMS) market in India growth during the next few years. Also, increasing number of US fda-approved manufacturing facilities and increasing outsourcing of research and manufacturing activities by smes will lead to sizable demand in the market.

The report on the contract research and manufacturing service (CRAMS) market in India covers the following areas:

  • Contract Research And Manufacturing Service (CRAMS) Market in India sizing
  • Contract Research And Manufacturing Service (CRAMS) Market in India forecast
  • Contract Research And Manufacturing Service (CRAMS) Market in India industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research and manufacturing service (CRAMS) market in India vendors that include Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., Bhagwati Organics Pvt. Ltd., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind-Swift Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma Pvt. Ltd., Onyx Scientific Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd. Also, the contract research and manufacturing service (CRAMS) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Service
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India: Year-over-year growth 2024-2029 (%)
Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023
Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million)
5.2 Service segment analysis 2019 - 2023
Historic Market Size - Service Segment 2019 - 2023 ($ million)
5.3 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Contract Research and Manufacturing Service (CRAMS) Market in India
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Service
8.1 Market segments
Chart on Service - Market share 2024-2029 (%)
Data Table on Service - Market share 2024-2029 (%)
8.2 Comparison by Service
Chart on Comparison by Service
Data Table on Comparison by Service
8.3 Manufacturing - Market size and forecast 2024-2029
Chart on Manufacturing - Market size and forecast 2024-2029 ($ million)
Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million)
Chart on Manufacturing - Year-over-year growth 2024-2029 (%)
Data Table on Manufacturing - Year-over-year growth 2024-2029 (%)
8.4 Research - Market size and forecast 2024-2029
Chart on Research - Market size and forecast 2024-2029 ($ million)
Data Table on Research - Market size and forecast 2024-2029 ($ million)
Chart on Research - Year-over-year growth 2024-2029 (%)
Data Table on Research - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Service
Market opportunity by Service ($ million)
Data Table on Market opportunity by Service ($ million)
9 Market Segmentation by Therapeutic Area
9.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
9.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
9.3 Cardiovascular - Market size and forecast 2024-2029
Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
9.4 Infectious disease - Market size and forecast 2024-2029
Chart on Infectious disease - Market size and forecast 2024-2029 ($ million)
Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million)
Chart on Infectious disease - Year-over-year growth 2024-2029 (%)
Data Table on Infectious disease - Year-over-year growth 2024-2029 (%)
9.5 Endocrine disease - Market size and forecast 2024-2029
Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Chart on Endocrine disease - Year-over-year growth 2024-2029 (%)
Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%)
9.6 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
10.4 Medical device companies - Market size and forecast 2024-2029
Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
10.5 Academic and research institutes - Market size and forecast 2024-2029
Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Technology
11.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
11.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
11.3 Bioinformatics - Market size and forecast 2024-2029
Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
11.4 Combinatorial chemistry - Market size and forecast 2024-2029
Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
11.5 High-throughput screening - Market size and forecast 2024-2029
Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Chart on High-throughput screening - Year-over-year growth 2024-2029 (%)
Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%)
11.6 Spectroscopy - Market size and forecast 2024-2029
Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Chart on Spectroscopy - Year-over-year growth 2024-2029 (%)
Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%)
11.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
11.8 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Aragen Life Sciences Pvt. Ltd.
Aragen Life Sciences Pvt. Ltd. - Overview
Aragen Life Sciences Pvt. Ltd. - Product / Service
Aragen Life Sciences Pvt. Ltd. - Key offerings
SWOT
15.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.7 Dhanuka Agritech Ltd.
Dhanuka Agritech Ltd. - Overview
Dhanuka Agritech Ltd. - Business segments
Dhanuka Agritech Ltd. - Key offerings
Dhanuka Agritech Ltd. - Segment focus
SWOT
15.8 Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. - Overview
Dishman Carbogen Amcis Ltd. - Business segments
Dishman Carbogen Amcis Ltd. - Key offerings
Dishman Carbogen Amcis Ltd. - Segment focus
SWOT
15.9 Divis Laboratories Ltd.
Divis Laboratories Ltd. - Overview
Divis Laboratories Ltd. - Product / Service
Divis Laboratories Ltd. - Key offerings
SWOT
15.10 Jubilant Pharmova Ltd.
Jubilant Pharmova Ltd. - Overview
Jubilant Pharmova Ltd. - Business segments
Jubilant Pharmova Ltd. - Key news
Jubilant Pharmova Ltd. - Key offerings
Jubilant Pharmova Ltd. - Segment focus
SWOT
15.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.13 MSN Laboratories
MSN Laboratories - Overview
MSN Laboratories - Product / Service
MSN Laboratories - Key offerings
SWOT
15.14 Onyx Scientific Ltd.
Onyx Scientific Ltd. - Overview
Onyx Scientific Ltd. - Product / Service
Onyx Scientific Ltd. - Key offerings
SWOT
15.15 Piramal Enterprises Ltd.
Piramal Enterprises Ltd. - Overview
Piramal Enterprises Ltd. - Product / Service
Piramal Enterprises Ltd. - Key offerings
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 TCG Lifesciences Pvt. Ltd.
TCG Lifesciences Pvt. Ltd. - Overview
TCG Lifesciences Pvt. Ltd. - Product / Service
TCG Lifesciences Pvt. Ltd. - Key offerings
SWOT
15.18 Wockhardt Ltd.
Wockhardt Ltd. - Overview
Wockhardt Ltd. - Business segments
Wockhardt Ltd. - Key offerings
Wockhardt Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Service
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 10: Overview on criticality of inputs and factors of differentiation
Exhibits 11: Overview on factors of disruption
Exhibits 12: Impact of drivers and challenges in 2024 and 2029
Exhibits 13: Parent Market
Exhibits 14: Data Table on - Parent Market
Exhibits 15: Market characteristics analysis
Exhibits 16: Value chain analysis
Exhibits 17: Offerings of companies included in the market definition
Exhibits 18: Market segments
Exhibits 19: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 20: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 21: Chart on India: Year-over-year growth 2024-2029 (%)
Exhibits 22: Data Table on India: Year-over-year growth 2024-2029 (%)
Exhibits 23: Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million)
Exhibits 24: Historic Market Size - Service Segment 2019 - 2023 ($ million)
Exhibits 25: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibits 28: Five forces analysis - Comparison between 2024 and 2029
Exhibits 29: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 30: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 31: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 32: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 34: Chart on Market condition - Five forces 2024 and 2029
Exhibits 35: Chart on Service - Market share 2024-2029 (%)
Exhibits 36: Data Table on Service - Market share 2024-2029 (%)
Exhibits 37: Chart on Comparison by Service
Exhibits 38: Data Table on Comparison by Service
Exhibits 39: Chart on Manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 40: Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 41: Chart on Manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 42: Data Table on Manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 43: Chart on Research - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Data Table on Research - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Chart on Research - Year-over-year growth 2024-2029 (%)
Exhibits 46: Data Table on Research - Year-over-year growth 2024-2029 (%)
Exhibits 47: Market opportunity by Service ($ million)
Exhibits 48: Data Table on Market opportunity by Service ($ million)
Exhibits 49: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 50: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 51: Chart on Comparison by Therapeutic Area
Exhibits 52: Data Table on Comparison by Therapeutic Area
Exhibits 53: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 56: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 57: Chart on Infectious disease - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Chart on Infectious disease - Year-over-year growth 2024-2029 (%)
Exhibits 60: Data Table on Infectious disease - Year-over-year growth 2024-2029 (%)
Exhibits 61: Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Chart on Endocrine disease - Year-over-year growth 2024-2029 (%)
Exhibits 64: Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%)
Exhibits 65: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 68: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 69: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 72: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 73: Market opportunity by Therapeutic Area ($ million)
Exhibits 74: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 75: Chart on End-user - Market share 2024-2029 (%)
Exhibits 76: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 77: Chart on Comparison by End-user
Exhibits 78: Data Table on Comparison by End-user
Exhibits 79: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits 82: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits 83: Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
Exhibits 85: Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits 86: Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits 87: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 89: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 90: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits 91: Market opportunity by End-user ($ million)
Exhibits 92: Data Table on Market opportunity by End-user ($ million)
Exhibits 93: Chart on Technology - Market share 2024-2029 (%)
Exhibits 94: Data Table on Technology - Market share 2024-2029 (%)
Exhibits 95: Chart on Comparison by Technology
Exhibits 96: Data Table on Comparison by Technology
Exhibits 97: Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on High-throughput screening - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Spectroscopy - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 117: Market opportunity by Technology ($ million)
Exhibits 118: Data Table on Market opportunity by Technology ($ million)
Exhibits 119: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 120: Impact of drivers and challenges in 2024 and 2029
Exhibits 121: Overview on criticality of inputs and factors of differentiation
Exhibits 122: Overview on factors of disruption
Exhibits 123: Impact of key risks on business
Exhibits 124: Companies covered
Exhibits 125: Company ranking index
Exhibits 126: Matrix on companies position and classification
Exhibits 127: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits 128: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits 129: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits 130: SWOT
Exhibits 131: Aurobindo Pharma Ltd. - Overview
Exhibits 132: Aurobindo Pharma Ltd. - Product / Service
Exhibits 133: Aurobindo Pharma Ltd. - Key offerings
Exhibits 134: SWOT
Exhibits 135: Biocon Ltd. - Overview
Exhibits 136: Biocon Ltd. - Business segments
Exhibits 137: Biocon Ltd. - Key offerings
Exhibits 138: Biocon Ltd. - Segment focus
Exhibits 139: SWOT
Exhibits 140: Dhanuka Agritech Ltd. - Overview
Exhibits 141: Dhanuka Agritech Ltd. - Business segments
Exhibits 142: Dhanuka Agritech Ltd. - Key offerings
Exhibits 143: Dhanuka Agritech Ltd. - Segment focus
Exhibits 144: SWOT
Exhibits 145: Dishman Carbogen Amcis Ltd. - Overview
Exhibits 146: Dishman Carbogen Amcis Ltd. - Business segments
Exhibits 147: Dishman Carbogen Amcis Ltd. - Key offerings
Exhibits 148: Dishman Carbogen Amcis Ltd. - Segment focus
Exhibits 149: SWOT
Exhibits 150: Divis Laboratories Ltd. - Overview
Exhibits 151: Divis Laboratories Ltd. - Product / Service
Exhibits 152: Divis Laboratories Ltd. - Key offerings
Exhibits 153: SWOT
Exhibits 154: Jubilant Pharmova Ltd. - Overview
Exhibits 155: Jubilant Pharmova Ltd. - Business segments
Exhibits 156: Jubilant Pharmova Ltd. - Key news
Exhibits 157: Jubilant Pharmova Ltd. - Key offerings
Exhibits 158: Jubilant Pharmova Ltd. - Segment focus
Exhibits 159: SWOT
Exhibits 160: Lupin Ltd. - Overview
Exhibits 161: Lupin Ltd. - Business segments
Exhibits 162: Lupin Ltd. - Key news
Exhibits 163: Lupin Ltd. - Key offerings
Exhibits 164: Lupin Ltd. - Segment focus
Exhibits 165: SWOT
Exhibits 166: Merck and Co. Inc. - Overview
Exhibits 167: Merck and Co. Inc. - Business segments
Exhibits 168: Merck and Co. Inc. - Key news
Exhibits 169: Merck and Co. Inc. - Key offerings
Exhibits 170: Merck and Co. Inc. - Segment focus
Exhibits 171: SWOT
Exhibits 172: MSN Laboratories - Overview
Exhibits 173: MSN Laboratories - Product / Service
Exhibits 174: MSN Laboratories - Key offerings
Exhibits 175: SWOT
Exhibits 176: Onyx Scientific Ltd. - Overview
Exhibits 177: Onyx Scientific Ltd. - Product / Service
Exhibits 178: Onyx Scientific Ltd. - Key offerings
Exhibits 179: SWOT
Exhibits 180: Piramal Enterprises Ltd. - Overview
Exhibits 181: Piramal Enterprises Ltd. - Product / Service
Exhibits 182: Piramal Enterprises Ltd. - Key offerings
Exhibits 183: SWOT
Exhibits 184: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 185: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 186: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 187: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 188: SWOT
Exhibits 189: TCG Lifesciences Pvt. Ltd. - Overview
Exhibits 190: TCG Lifesciences Pvt. Ltd. - Product / Service
Exhibits 191: TCG Lifesciences Pvt. Ltd. - Key offerings
Exhibits 192: SWOT
Exhibits 193: Wockhardt Ltd. - Overview
Exhibits 194: Wockhardt Ltd. - Business segments
Exhibits 195: Wockhardt Ltd. - Key offerings
Exhibits 196: Wockhardt Ltd. - Segment focus
Exhibits 197: SWOT
Exhibits 198: Inclusions checklist
Exhibits 199: Exclusions checklist
Exhibits 200: Currency conversion rates for US$
Exhibits 201: Research methodology
Exhibits 202: Information sources
Exhibits 203: Data validation
Exhibits 204: Validation techniques employed for market sizing
Exhibits 205: Data synthesis
Exhibits 206: 360 degree market analysis
Exhibits 207: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the contract research and manufacturing service (CRAMS) market in india: Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., Bhagwati Organics Pvt. Ltd., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind-Swift Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma Pvt. Ltd., Onyx Scientific Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in crams."

According to the report, one of the major drivers for this market is the diverse range of service offerings by crams providers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aragen Life Sciences Pvt. Ltd.
  • Arch Pharmalabs Ltd.
  • Aurobindo Pharma Ltd.
  • Bhagwati Organics Pvt. Ltd.
  • Biocon Ltd.
  • Dhanuka Agritech Ltd.
  • Dishman Carbogen Amcis Ltd.
  • Divis Laboratories Ltd.
  • Ind-Swift Laboratories Ltd.
  • Jubilant Pharmova Ltd.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • MSN Laboratories
  • Murli Krishna Pharma Pvt. Ltd.
  • Onyx Scientific Ltd.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • TCG Lifesciences Pvt. Ltd.
  • Wockhardt Ltd.